Phase II study of emetine (NSC-33669) in the treatment of solid tumors.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood; D004341:Drug Evaluation; D004640:Emetine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
D003402:Creatine Kinase; D004640:Emetine